Extracorporeal support for patients with acute and acute on chronic liver failure

References

• Williams R, Aspinall R, Bellis M, et al Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 2014;384:1953–1997.
   PubMed Web of Science ®Google Scholar
• National Health Service Right Care. Liver disease: the NHS atlas of variation in healthcare for people with liver disease; 2013. Available from: http://www.rightcare.nhs.uk/index.php/atlas/liver-disease-nhs-atlas-of-variation- in-healthcare-for-people-with-liver-disease
   Google Scholar
• Part of Deaths Related to Drug Poisoning, England and Wales - 2013 Release. Available from: http://www.ons.gov.uk/ons/rel/subnational-health3/deaths-related-to-drug-poisoning/england-and-wales—2013/stb—deaths-related-to-drug-poisoning-in-england-and-wales–2013.html
   Google Scholar
• The World Health Organisation. Available from: www.WHO.int
   Google Scholar
• Sheron N, Chilcot F, Matthews L, et al. Impact of minimum price per unit of alcohol on patients with liver disease in the UK. Clin Med. 2014;14:396–403.
   PubMed Web of Science ®Google Scholar
• Department of Health (UK). Safe, sensible, social: the government’s alcohol strategy; 2008. Available from: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publichealth/Healthimprovement/Alcoholmisuse/DH_085386
   Google Scholar
• Armstrong MJ, Houlihan DD, Bentham L, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol. 2012;56:234–240.
   PubMed Web of Science ®Google Scholar
• O’Grady JG, Schalm SW. Williams R: Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–275.
   PubMed Web of Science ®Google Scholar
• Rony E, et al Small for size liver remnant following resection: prevention and management. Hepatobiliary Surg Nutr. 2014 Oct;3(5):303–312.
   PubMedGoogle Scholar
• Yamauchi A, Fukuhara Y, Yamamoto S, et al. Oncotic pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat hepatoma cells. Am J Physiol. 1992;263(2 Pt 1):C397–404.
   PubMed Web of Science ®Google Scholar
• Anraku M, Chuang VT, Maruyama T, et al. Redox properties of serum albumin. Biochim Biophys Acta. 2013;1830(12):5465–5472.
   PubMed Web of Science ®Google Scholar
• Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55(4):820–829.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649.
   PubMed Web of Science ®Google Scholar
• Klammt S, Mitzner SR, Stange J, et al. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl. 2008;14(9):1333–1339.
   PubMed Web of Science ®Google Scholar
• Jalan R, Schnurr K, Mookerjee RP, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009;50(2):555–564.
   PubMed Web of Science ®Google Scholar
• Oettl K, Birner-Gruenberger R, Spindelboeck W, et al. Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J Hepatol. 2013;59(5):978–983.
   PubMed Web of Science ®Google Scholar
• Wade J, Rolando N, Philpott-Howard J, et al. Timing and aetiology of bacterial infections in a liver intensive care unit. J Hosp Infect. 2003;53:144–146.
   PubMed Web of Science ®Google Scholar
• Clapperton M, Rolando N, Sandoval L, et al. Neutrophil superoxide and hydrogen peroxide production in patients with acute liver failure. Eur J Clin Invest. 1997;27:164–168.
   PubMed Web of Science ®Google Scholar
• Bernal W, Hall C, Karvellas CJ, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–1852.
   PubMed Web of Science ®Google Scholar
• Norenberg MD, Rao KV, Jayakumar AR. Mechanisms of ammonia-induced astrocyte swelling. Metab Brain Dis. 2005;20:303–318.
   PubMed Web of Science ®Google Scholar
• Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32:734–739.
   PubMed Web of Science ®Google Scholar
• Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310–1318.
   PubMed Web of Science ®Google Scholar
• Parekh NK, Hynan LS, De Lemos J, et al. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology. 2007;45:1489–1495.
   PubMed Web of Science ®Google Scholar
• www.odt.nhs.uk/pdf/organ_specific_report_liver_2014.pdf
   Google Scholar
• Benedum J. The early history of the artificial kidney. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003;38:681–688.
   PubMed Web of Science ®Google Scholar
• Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2015;PMID:26325537.
   Google Scholar
• Ash SR. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther. 2002;9:3–18.
   PubMedGoogle Scholar
• Stange J, Mitzner S, Ramlo W, Method for the separation of protein-bound substances from a protein-containing liquid by dialysis. US-Patent 5.078.885. 1998 Apr 28.
   Google Scholar
• Konstantin P, Chang J, Otto V, et al. Artificial liver. Artif Organs. 1992;16:235–242.
   PubMed Web of Science ®Google Scholar
• Stange J, Mitzner S, Ramlow W, et al. A new procedure for the removal of protein bound drugs and toxins. Asaio J. 1993;39:621–625.
   PubMedGoogle Scholar
• Agarwal B, Wright G, Gatt A, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol. 2012;57(4):780–786.
   PubMed Web of Science ®Google Scholar
• Agarwal B, Gatt A, Riddell A, et al. Hemostasis in patients with acute kidney injury secondary to acute liver failure. Kidney Int. 2013;84(1):158–163.
   PubMed Web of Science ®Google Scholar
• Agarwal B, Shaw S, Shankar Hari M, et al. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? J Hepatol. 2009;51(3):504–509.
   PubMed Web of Science ®Google Scholar
• Bañares R, Nevens F, Larsen FS, et al. Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure. The RELIEF trial. J Hepatol. 2010;52(S1):S459–S460.
   Google Scholar
• Hassanein TI, Tofteng F, Brown RS Jr, et al. Randomized controlled study of extracorporeal albumin dialysisfor hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007;46(6):1853–1862.
   PubMed Web of Science ®Google Scholar
• Zhou N, Li J, Zhang Y, et al. Efficacy of coupled low-volume plasma exchange with plasma filtration adsorption in treating pigs with acute liver failure: A randomised study. J Hepatol. 2015;63(2):378–387.
   PubMed Web of Science ®Google Scholar
• Lee KC, Baker LA, Stanzani G, et al. Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: results of a pivotal pre-clinical study. J Hepatol. 2015;63(3):634–642.
   PubMed Web of Science ®Google Scholar
• Stevens AC, Busuttil R, Han S, et al. An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the Hepatassist(R) bioartificial liver support system for the treatment of fulminant hepatic failure. Hepatology. 2001;34:299A.
   Web of Science ®Google Scholar
• Rozga J, Umehara Y, Trofimenko A, et al. A novel plasma filtration therapy for hepatic failure: preclinical studies. Ther Apher Dial. 2006;10:138–144.
   PubMed Web of Science ®Google Scholar
• Leckie P, Davenport A, Jalan R. Extracorporeal liver support. Blood Purif. 2012;34(2):158–163.
   PubMed Web of Science ®Google Scholar
• Kribben A, Gerken G, Haag S, HELIOS Study Group, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142(4):782–789.e3.
   PubMed Web of Science ®Google Scholar
• Parés A, Herrera M, Avilés J, et al. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol. 2010;53(2):307–312.
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Laleman W, Wilmer A, et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs. 2006;30(4):276–284.
   PubMed Web of Science ®Google Scholar
• Krisper P, Haditsch B, Stauber R, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol. 2005;43(3):451–457.
   PubMed Web of Science ®Google Scholar
• Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit. Care. 2006;10(4):R108.
   PubMed Web of Science ®Google Scholar
• Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993;21(3):328–338.
   PubMed Web of Science ®Google Scholar
• Davenport A, Will EJ, Losowsky MS, et al. Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure. Br Med J (Clin Res Ed). 1987;295(6605):1028.
   PubMed Web of Science ®Google Scholar
• Ryska M, Laszikova E, Pantoflicek T, et al. Fractionated plasma separation and adsorption significantly decreases intracranial pressure in acute liver failure: experimental study. Eur Surg Res. 2009;42(4):230–235.
   PubMed Web of Science ®Google Scholar
• Sen S, Rose C, Ytrebø LM. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med. 2006;34(1):158–164.
   PubMed Web of Science ®Google Scholar
• Schmidt LE, Svendsen LB, Sørensen VR, et al. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl. 2001;7(8):709–712.
   PubMed Web of Science ®Google Scholar
• Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl. 2004;10(9):1109–1119.
   PubMed Web of Science ®Google Scholar
• Heemann U, Treiche L, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: aprospective, controlled study. Hepatology. 2002;36(4 pt 1):949–958.
   PubMed Web of Science ®Google Scholar
• Adebayo D, Morabito V, Davenport A, et al. Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney Int. 2015;87(3):509–515.
   PubMed Web of Science ®Google Scholar
• Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl. 2000;6(3):277–286.
   PubMed Web of Science ®Google Scholar
• Rifai K, Ernst T, Kretschmer U, et al. Removal selectivity of Prometheus: a new extracorporeal liver support device. World J Gastroenterol. 2006;12(6):940–944.
   PubMed Web of Science ®Google Scholar
• Rifai K, Kribben A, Gerken G, et al. Extracorporeal liver support by fractionated plasmas eparation and absorption (Prometheus®) in patients with acute-on-chronic liver failure (HELIOS study): a prospective randomized controlled multicenter study. J Hepatol. 2010;52(S1):S3.
   PubMed Web of Science ®Google Scholar
• Rifai K, Ernst T, Kretschmer U, et al. The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif. 2005;23(4):298–302.
   PubMed Web of Science ®Google Scholar
• Schmidt LE, Wang LP, Hansen BA, et al. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl. 2003;9(3):290–297.
   PubMed Web of Science ®Google Scholar
• Khuroo MS, Khuroo MS, Farahat KLC. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl. 2004;10(9):1099–1106.
   PubMed Web of Science ®Google Scholar
• Saliba F, Camus C, Durand F, et al. Randomized controlled multicenter trial evaluating the efficacy and safety of albumin dialysis with MARS® in patients with fulminant and subfulminant hepatic failure. Presented at: The 59th Annual meeting of the American Association for the Study of Liver Diseases. CA, USA; 2008 Oct 31–Nov 4.
   Google Scholar
• Kortgen A, Rauchfuss F, Gotz M, et al. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis - a retrospective analysis. Ther Apher and Dial. 2009;13:419–425.
   PubMed Web of Science ®Google Scholar
• Flendrig LM, La Soe JW, Jorning GG, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol. 1997;26:1379–1392.
   PubMed Web of Science ®Google Scholar
• Van De Kerkhove MP, Di Florio E, Scuderi V, et al. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs. 2002;25:950–959.
   PubMed Web of Science ®Google Scholar
• Samuel D, Ichai P, Feray C, et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation. 2002;73:257–264.
   PubMed Web of Science ®Google Scholar
• Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239:660–670.
   PubMed Web of Science ®Google Scholar
• Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 1996;24:1446–1451.
   PubMed Web of Science ®Google Scholar
• Millis JM, Kramer DJ, O’Grady J, et al. Results of phase I trial of the extracorporeal liver assist device for patients with fulminant hepatic failure. Am J Transplant. 2001;1(suppl1):391.
   Google Scholar
• VTI-208 Phase 3 Clinical Trial in Alcohol-Induced Liver Decompensation (AILD) and Severe Acute Alcoholic Hepatitis (sAAH). Available from: http://vitaltherapies.com/clinical-trials/
   Google Scholar
• Sauer IM, Kardassis D, Zeillinger K, et al. Clinical extracorporeal hybrid liver support - phase I study with primary porcine liver cells. Xenotransplantation. 2003;10:460–469.
   PubMed Web of Science ®Google Scholar
• Glorioso JM, Mao SA, Rodysill B, et al. Pivotal preclinical trial of the spheroid reservoir bioartificial liver. J Hepatol. 2015;63(2):388–398.
   PubMed Web of Science ®Google Scholar
• Davenport A. What are the anticoagulation options for intermittent hemodialysis? Nat Rev Nephrol. 2011;7(9):499–508.
   PubMed Web of Science ®Google Scholar
• Davenport A, Tolwani A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus. 2009;2(6):439–447.
   PubMedGoogle Scholar
• Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016 Jan;64(1):69–78.
   PubMed Web of Science ®Google Scholar
• Zhong-Ping Duan JZ, Xin X, Chen JM, et al. Interim results of randomised controlled trialof ELAD in acute on chronic liver disease. Hepatology. 2007;46:274A.
   Web of Science ®Google Scholar
• Mazariegos GV, Patzer JF 2nd, Lopez RC, et al. First clinical use of a novel bioartificial liver support system (BLSS)+. Am J Transplant. 2002 Mar;2(3):260–266.
   PubMed Web of Science ®Google Scholar
• Kang JH, Super M, Yung CW, et al. An extracorporeal blood-cleansing device for sepsis therapy. Nat Med. 2014 Oct;20(10):1211–1216.
   PubMed Web of Science ®Google Scholar
• Leslie DC, Waterhouse A, Berthet JB, et al. A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling. Nat Biotechnol. 2014 Nov;32(11):1134–1140.
   PubMed Web of Science ®Google Scholar